Amundi Has $5.04 Million Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Amundi lowered its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 22.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 82,518 shares of the company’s stock after selling 23,600 shares during the quarter. Amundi’s holdings in Ryan Specialty were worth $5,044,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in RYAN. Assetmark Inc. acquired a new stake in Ryan Specialty in the 3rd quarter worth approximately $34,000. Principal Securities Inc. boosted its holdings in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock worth $43,000 after buying an additional 415 shares during the period. Quarry LP boosted its holdings in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock worth $54,000 after buying an additional 422 shares during the period. Loomis Sayles & Co. L P raised its holdings in Ryan Specialty by 26.3% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after acquiring an additional 286 shares during the period. Finally, R Squared Ltd acquired a new position in Ryan Specialty during the 4th quarter worth $92,000. Institutional investors own 84.82% of the company’s stock.

Insider Activity at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $65.17, for a total transaction of $2,280,950.00. Following the transaction, the director now owns 50,400 shares in the company, valued at $3,284,568. This represents a 40.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold 281,451 shares of company stock valued at $18,549,143 in the last three months. Corporate insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

RYAN has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods dropped their price objective on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research note on Friday, February 21st. Barclays upped their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. Wells Fargo & Company raised their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a research note on Friday, February 21st. Morgan Stanley initiated coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price for the company. Finally, UBS Group raised their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $75.27.

Ryan Specialty Stock Performance

Ryan Specialty stock opened at $69.86 on Friday. The firm has a market capitalization of $18.30 billion, a P/E ratio of 101.25, a P/E/G ratio of 1.19 and a beta of 0.71. The stock has a fifty day moving average price of $67.11 and a two-hundred day moving average price of $67.74. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The firm had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th will be given a dividend of $0.12 per share. The ex-dividend date is Tuesday, March 4th. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.69%. Ryan Specialty’s dividend payout ratio is 69.57%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.